Cambridge Isotope Laboratories and Chemtatva ink JV for advanced manufacturing capabilities in TelanganaIllustrative image – not actual.

Cambridge Isotope Laboratories (CIL), a US-based manufacturer of stable isotope-labelled compounds, has entered into a joint venture (JV) with Hyderabad’s Chemtatva Chiral Solutions to establish advanced manufacturing capabilities in Telangana.

The JV plans to invest Rs 300 crore over the next three years in Genome Valley Phase 4. The new facility will focus on the production of stable isotope–labelled compounds essential for pharmaceutical research, diagnostics, advanced electronics, and semiconductor applications. The initiative aims to create over 250 work opportunities and strengthen India’s expertise in this specialised segment, reducing the country’s reliance on imports. The facility will cater to drug discovery, metabolic studies, diagnostics, and materials research, contributing significantly to the life sciences and advanced materials sectors.

Shakthi M. Nagappan, CEO of Telangana Life Sciences, emphasised that the venture would bolster India’s capabilities in this crucial area, supporting the country’s growing role in global pharmaceutical and electronics research.

← All latest storiesBack to top →